T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Nucor
NUE
$61.7B
| $136M | 0.02% |
1,302,040
+272,987
| +27% | +$36.9M |
|
577
US Physical Therapy
USPH
$1.22B
| $136M | 0.02% |
1,243,897
+1,260
| +0.1% | +$134K |
|
578
Denali Therapeutics
DNLI
$4.04B
| $136M | 0.02% |
4,610,177
-313,248
| -6% | -$8.21M |
|
579
CenterPoint Energy
CNP
$26.7B
| $135M | 0.02% |
4,559,357
-3,724,480
| -45% | -$115M |
|
|
SPR
580
DELISTED
Spirit AeroSystems
SPR
| $135M | 0.02% |
4,591,729
+4,525,393
| +6,822% | +$162M |
|
581
Planet Fitness
PLNT
$3.65B
| $134M | 0.02% |
1,973,636
-227,289
| -10% | -$16.8M |
|
|
NARI
582
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $134M | 0.02% |
1,966,302
+356,309
| +22% | +$25.6M |
|
583
Lockheed Martin
LMT
$140B
| $133M | 0.02% |
309,879
-57,416
| -16% | -$25.2M |
|
584
Arthur J. Gallagher & Co
AJG
$65.5B
| $133M | 0.02% |
815,720
-96,540
| -11% | -$16M |
|
585
Extra Space Storage
EXR
$31B
| $133M | 0.02% |
779,098
+398,729
| +105% | +$73.9M |
|
586
ScottsMiracle-Gro
SMG
$3.62B
| $131M | 0.02% |
1,661,229
+347,852
| +26% | +$34.4M |
|
587
WSFS Financial
WSFS
$4.15B
| $129M | 0.02% |
3,224,607
-39,167
| -1% | -$1.61M |
|
|
BWIN
588
Baldwin Insurance Group
BWIN
$3B
| $128M | 0.02% |
5,315,328
-134,335
| -2% | -$3.27M |
|
589
Independent Bank
INDB
$4.04B
| $128M | 0.02% |
1,614,612
-48,564
| -3% | -$3.86M |
|
590
Marriott Vacations Worldwide
VAC
$4.1B
| $128M | 0.02% |
1,101,097
-15,850
| -1% | -$2.23M |
|
591
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
| $128M | 0.02% |
3,372,740
-39,698
| -1% | -$1.58M |
|
592
Procept Biorobotics
PRCT
$1.22B
| $128M | 0.02% |
3,904,003
+58,511
| +2% | +$2.13M |
|
593
Gilead Sciences
GILD
$168B
| $127M | 0.02% |
2,057,291
-444,414
| -18% | -$27.5M |
|
594
Freshpet
FRPT
$3.48B
| $127M | 0.02% |
2,448,243
-164,047
| -6% | -$12.7M |
|
595
California Water Service
CWT
$3.09B
| $127M | 0.02% |
2,278,162
+9,949
| +0.4% | +$536K |
|
596
Regal Rexnord
RRX
$11.5B
| $126M | 0.02% |
1,112,977
+7,253
| +0.7% | +$922K |
|
597
NVR
NVR
$16.8B
| $126M | 0.02% |
31,481
-6,035
| -16% | -$25.7M |
|
598
AerCap
AER
$23.6B
| $126M | 0.02% |
3,070,515
+257,011
| +9% | +$11.9M |
|
599
Enbridge
ENB
$112B
| $124M | 0.02% |
2,944,604
+1,469,957
| +100% | +$65.6M |
|
|
AIV
600
Aimco
AIV
$379M
| $124M | 0.02% |
19,420,797
-482,553
| -2% | -$3.04M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.